Mojgan Hessamfar

801 total citations
23 papers, 198 citations indexed

About

Mojgan Hessamfar is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mojgan Hessamfar has authored 23 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Mojgan Hessamfar's work include HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (8 papers) and HIV-related health complications and treatments (8 papers). Mojgan Hessamfar is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (8 papers) and HIV-related health complications and treatments (8 papers). Mojgan Hessamfar collaborates with scholars based in France, Tunisia and Mali. Mojgan Hessamfar's co-authors include Fabrice Bonnet, D. Neau, François Dabis, Charles Cazanave, Sophie Farbos, P. Morlat, S. Lawson‐Ayayi, S. Geffard, JL Pellegrin and Mathias Bruyand and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Mojgan Hessamfar

21 papers receiving 195 citations

Peers

Countries citing papers authored by Mojgan Hessamfar

Since Specialization

Citations

This map shows the geographic impact of Mojgan Hessamfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojgan Hessamfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojgan Hessamfar more than expected).

Fields of papers citing papers by Mojgan Hessamfar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojgan Hessamfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojgan Hessamfar. The network helps show where Mojgan Hessamfar may publish in the future.

Co-authorship network of co-authors of Mojgan Hessamfar

This figure shows the co-authorship network connecting the top 25 collaborators of Mojgan Hessamfar. A scholar is included among the top collaborators of Mojgan Hessamfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojgan Hessamfar. Mojgan Hessamfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of extending PrEP initiation to primary care settings: a nationwide cohort study in France 2025 ·The Lancet Public Health ·(unknown), Sophie Billioti de Gage, (unknown), (unknown), (unknown), (unknown), François Dabis, (unknown), Mojgan Hessamfar, (unknown), Rosemary Dray‐Spira, Michel Carlès	1
2	A case of lenacapavir use for preventing mother-to-child HIV transmission 2024 ·Journal of Antimicrobial Chemotherapy ·(unknown), Stéphane Bouchet, Emmanuel Ribeiro, (unknown), Christophe Elleau, Caroline Solas, Alexandre Destère, Mojgan Hessamfar, Camille Tumiotto, Fabrice Bonnet	3
3	Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018–2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study) 2023 ·Scientific Reports ·Diana Barger, Mojgan Hessamfar, D. Neau, Sophie Farbos, Olivier Leleux, Charles Cazanave, (unknown), P. Duffau, Estibaliz Lazaro, P Rispal, François Dabis, Linda Wittkop, Fabrice Bonnet	7
4	Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study) 2023 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jihane Ben Farhat, Mojgan Hessamfar, Sophie Farbos, Arnaud Desclaux, (unknown), (unknown), C. Greib, Bernard Castan, P Rispal, P. Duffau, Olivier Leleux, (unknown), Linda Wittkop, Fabrice Bonnet, Diana Barger	0
5	Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients? 2022 ·Journal of Clinical Medicine ·Fabrice Camou, Nahéma Issa, Mojgan Hessamfar, Olivier Guisset, (unknown), (unknown), (unknown), Fabrice Bonnet	5
6	A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population 2022 ·Scientific Reports ·(unknown), Mojgan Hessamfar, D. Neau, Marc-Olivier Vareil, (unknown), Estibaliz Lazaro, P. Duffau, Charles Cazanave, P Rispal, Valérie Gaborieau, Olivier Leleux, Linda Wittkop, Fabrice Bonnet, Diana Barger	9
7	Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007–2018 2022 ·International Journal of Antimicrobial Agents ·(unknown), Pantxika Bellecave, Linda Wittkop, (unknown), P. Duffau, Estibaliz Lazaro, Marc-Olivier Vareil, Camille Tumiotto, Mojgan Hessamfar, Charles Cazanave, (unknown), Olivier Leleux, Fabrice Bonnet, D. Neau	1
8	Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study 2020 ·Health and Quality of Life Outcomes ·Diana Barger, Mojgan Hessamfar, D. Neau, Marc-Olivier Vareil, (unknown), (unknown), (unknown), Olivier Leleux, (unknown), (unknown), Linda Wittkop, François Dabis, Fabrice Bonnet	6
9	High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program 2019 ·Médecine et Maladies Infectieuses ·(unknown), Sabine Pereyre, Mathilde Pugès, Cécile Bébéar, Alice Desclaux, Mojgan Hessamfar, Chloé Le Roy, (unknown), (unknown), Charles Cazanave	13
10	High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection 2017 ·Journal of Antimicrobial Chemotherapy ·(unknown), Marie-Anne Vandenhende, (unknown), (unknown), Pantxika Bellecave, Camille Tumiotto, Véronique Avettand-Fènoël, Mojgan Hessamfar, Philippe Morlat, Fabrice Bonnet	4
11	Mycoplasma genitalium chez les PrEPeurs : mythe ou réalité ? 2017 ·Médecine et Maladies Infectieuses ·(unknown), Sabine Pereyre, Cécile Bébéar, Mojgan Hessamfar, (unknown), François Dabis, Charles Cazanave	0
12	Couverture vaccinale dans une cohorte de patients vivant avec le VIH suivis dans un CHU : étude prospective transversale, 25 janvier–12 février 2016, France 2017 ·Médecine et Maladies Infectieuses ·(unknown), Fabrice Bonnet, Mojgan Hessamfar, D. Lacoste, P. Morlat, Thierry Pistone, Denis Malvy, (unknown)	1
13	AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000–2008: hospital-based cohort studies 2014 ·BMC Infectious Diseases ·(unknown), Paula M. Luz, Mathias Bruyand, Sayonara Ribeiro, Fabrice Bonnet, Ronaldo I. Moreira, Mojgan Hessamfar, (unknown), C. Greib, Charles Cazanave, Valdiléa G. Veloso, François Dabis, Beatriz Grinsztejn, Geneviève Chêne	24
14	Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients 2014 ·BMC Infectious Diseases ·Nora Frulio, Hervé Trillaud, Paul Perez, Julien Asselineau, (unknown), Mojgan Hessamfar, Fabrice Bonnet, Florent Maire, (unknown), Victor de Lédinghen, Philippe Morlat	23
15	Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response 2014 ·Journal of Infection ·Evguenia Krastinova, Firouzé Bani‐Sadr, (unknown), Cécile Goujard, Mojgan Hessamfar, Yazdan Yazdanpanah, Stanislas Pol, P. Cacoub, Christian Perronne, Fabrice Carrat	1
16	Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort 2014 ·PLoS ONE ·Mojgan Hessamfar, Céline Colin, Mathias Bruyand, (unknown), Fabrice Bonnet, P. Mercié, D. Neau, Charles Cazanave, Jean‐Luc Pellegrin, François Dabis, Philippe Morlat, Geneviève Chêne, (unknown)	10
17	Purpura thrombotique thrombocytopénique induit par l’interféron chez une femme co-infectée par le VIH et le VHC 2013 ·La Revue de Médecine Interne ·(unknown), (unknown), M.A. Vandenhende, Mojgan Hessamfar, P. Morlat, Françoise Bonnet	3
18	Adéquation entre les prescriptions antibiotiques et les recommandations dans un service de médecine interne : une démarche d’évaluation des pratiques professionnelles 2013 ·La Revue de Médecine Interne ·(unknown), M.A. Vandenhende, Fabrice Bonnet, D. Lacoste, N. Bernard, (unknown), Mojgan Hessamfar, (unknown), P. Morlat	2
19	Chronic Viral Hepatitis Is Associated With Low Bone Mineral Density in HIV-Infected Patients, ANRS CO 3 Aquitaine Cohort 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·S. Lawson‐Ayayi, Charles Cazanave, Alphonse Kpozéhouen, Nicole Barthe, Nadia Mehsen, Mojgan Hessamfar, M. Dupon, François Dabis, D. Neau	8
20	Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort 2011 ·International Journal of STD & AIDS ·(unknown), Mojgan Hessamfar, S. Lawson‐Ayayi, D. Neau, S. Geffard, Sophie Farbos, (unknown), (unknown), JL Pellegrin, (unknown), François Dabis, P. Morlat	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact